強生醫學技術

2023年6月27日

5天改變今天上午06:31分享馬爾伯勒,質量。2023年6月27日,波士頓科技公司(NYSE: BSX)今天宣布的選舉傑西卡·l .兆和蘇珊·e·Morano董事會,每個立即生效。大型博士是實實在在的生命科學公司的聯合創始人,字母的子公司公司專注於生命科學和醫療保健,和公司的首席醫學和科學從2015年到2023年1月。加入實在之前,大型博士擔任心髒病專家布裏格姆與婦女醫院從2008年到2015年。大型博士還擔任哈佛醫學院教員和高級調查員TIMI研究小組,在那裏她領導國際試驗評價小說心血管治療和指導基因組計劃。目前她是Danaher集團的董事。大型博士從斯坦福大學獲得學士學位,她從耶魯大學醫學院的醫學博士,她從哈佛大學公共衛生學院的。。Morano女士舉行了副總裁的角色,業務發展和戰略業務,強生醫學技術從2020年到2023年2月。在此之前,她擔任副總裁,業務發展,強生醫療器械,從2012年開始,負責許可、收購和資產剝離的醫療設備組。Morano女士在強生(Johnson & Johnson)期間,還舉行一些倉位在6操作公司,主要在金融和商業開發功能,以及醫學技術領導團隊的一員。 Ms. Morano received her B.S. from Villanova University and her M.B.A. from Columbia Business School. "We are pleased to expand our board of directors with two highly qualified executives from different sectors of the healthcare industry," said Mike Mahoney, chief executive and chairman of the board, Boston Scientific. "Jessica and Susan are accomplished leaders passionate about advancing patient care and experienced in bringing innovative technologies to market, and we look forward to their contributions as board members as Boston Scientific continues to grow and meet our stakeholder commitments." About Boston Scientific Boston Scientific transforms lives through innovative medical solutions that improve the health of patients around the world. As a global medical technology leader for more than 40 years, we advance science for life by providing a broad range of high performance solutions that address unmet patient needs and reduce the cost of healthcare. For more information, visit www.bostonscientific.com and connect on Twitter and Facebook. CONTACTS